The challenges in colorectal cancer management during COVID-19 epidemic | Zendy

Xianghai Ren | Zendy; Baoxiang Chen | Zendy; Yuntian Hong | Zendy; Weicheng Liu | Zendy; Qi Jiang | Zendy; Jingying Yang | Zendy; Qun Qian | Zendy; Congqing Jiang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The challenges in colorectal cancer management during COVID-19 epidemic

Author(s) -

Xianghai Ren,

Baoxiang Chen,

Yuntian Hong,

Weicheng Liu,

Qi Jiang,

Jingying Yang,

Qun Qian,

Congqing Jiang

Publication year - 2020

Publication title -

annals of translational medicine

Language(s) - English

Resource type - Journals

eISSN - 2305-5847

pISSN - 2305-5839

DOI - 10.21037/atm.2020.03.158

Subject(s) - medicine , colorectal cancer , covid-19 , disease , intensive care medicine , outbreak , stage (stratigraphy) , cancer , therapeutic approach , pathology , infectious disease (medical specialty) , biology , paleontology

It has been over 2 months since the start of the Coronavirus disease 2019 (COVID-19) outbreak. The epidemic stage of COVID-19 has brought great challenges to the diagnosis and management of colorectal cancer (CRC) patients. Symptoms, such as fever and cough caused by cancer, and the therapeutic process (including chemotherapy and surgery) should be differentiated from some COVID-19 related characteristics. Besides, clinical workers should not only consider the therapeutic strategy for cancer, but also emphasize COVID-19's prevention. Moreover, the detailed therapeutic regimens of CRC patients may be different from the usual. Also, treatment principles may various for CRC patients with or without severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, as well as patients with or without an emergency presentation. In this paper, we want to discuss the above-mentioned problems based on previous guidelines, the current working status and our experiences, to provide a reference for medical personnel.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research